Ordering Recommendation

Preferred panel for diagnosing possible tick-borne disease (ie, Anaplasmosis, Ehrlichiosis, or Babesiosis) during the acute phase of the disease.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Lavender (EDTA) or Pink (K2EDTA).

Specimen Preparation

Transport 1 mL whole blood. (Min: 0.6 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Serum, plasma, and heparinized specimens.

Remarks
Stability

Ambient: 24 hours; Refrigerated: 1 week; Frozen: 1 week

Methodology

Qualitative Polymerase Chain Reaction

Performed

Sun-Sat

Reported

1-3 days

Reference Interval

Available Separately
Components
Reference Interval
Yes (2008665) Babesia Species by PCR Refer to report
Yes (2007862) Ehrlichia and Anaplasma Species by PCR Refer to report

Interpretive Data

Refer to individual components.

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.

Compliance Category

Laboratory Developed Test (LDT)

Note

Hotline History

N/A

CPT Codes

87468; 87484; 87798 x3; 87469

Components

Component Test Code* Component Chart Name LOINC
2007863 Anaplasma phagocytophilum by PCR 30039-2
2007865 Ehrlichia chaffeensis by PCR 27994-3
2007867 Ehrlichia ewingii/canis by PCR 48865-0
2007869 Ehrlichia muris-like by PCR 48866-8
2008666 Babesia species by PCR 88233-2
2008668 Babesia microti by PCR 21089-8
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

Tick-Borne Disease Panel by PCR, Blood